As Trump’s trade war led stocks to post their worst first quarter since 2022, diversification proved its worth.
With large opportunities in its target markets, management aims to continue growing at a fast pace with a long-term annual earnings per share growth goal of 11%-15%. While Humana appears focused ...
Teresa Ribera's trip--which combines a gathering of antitrust lawyers with a meeting with Federal Trade Commission Chair Andrew N. Ferguson and top officials from Mexico and Canada--also comes as her ...
Continental warned of high levels of uncertainty after President Trump pledged to impose 25% tariffs on global automotive imports into the U.S. Trump said last week that the tariffs--to be applied on ...
More than 60% of operating profit is derived from resilient categories with low private label penetration and strong brand loyalty, where Nestle exhibits evident pricing power.
The STOXX Europe 600 Index is up 5.72 points or 1.07% today to 539.64 --Largest one day point and percentage gain since Friday, March 14, 2025 ...
--Mercedes-Benz Group may withdraw its least expensive U.S. vehicles because President Trump's tariffs on auto imports could make their sales economically unfeasible, Bloomberg reports, citing people ...
After a brief early push higher, crude oil contracts were staying close to Monday levels. The NYMEX May West Texas Intermediate contract, which rose to a roughly six-week high in morning trading of ...
Tesla Inc. reports first-quarter delivery numbers Wednesday, with the electric-vehicle maker in the center of a storm of protests against its polarizing chief executive, Elon Musk.
The Invesco S&P 500 Low Volatility ETF SPLV tracks the S&P 500 Low Volatility Index, which is maintained by S&P Dow Jones Indices. The fund holds the 100 stocks in the S&P 500 with the lowest price ...
Bernstein Research analyst Stacy Rasgon noted that Tan is known for looking to "underpromise and overdeliver," which Rasgon said makes the most sense right now for Intel. "At least he clearly does not ...
Naturally, Cigna's bulked-up service offerings should allow it to cross-sell traditional PBM and specialty pharmacy services into its managed-care client set and vice versa, opening up new profit ...